Arzeda to Lead Major NSF-Funded Initiative Advancing Cell-Free Manufacturing Through AI-Designed Enzymes

Consortium project totaling nearly $6.3 million broadens the economic reach of sustainable biomanufacturing

SEATTLE, Sept. 8, 2025 /PRNewswire/ -- Arzeda, The Protein Design Company™, today announced it has been selected to lead a highly competitive U.S. National Science Foundation (NSF) award as part of NSF's Use Inspired Acceleration of Protein Design (NSF USPRD) initiative. The award, totaling approximately $6.3 million, will harness Arzeda's Intelligent Protein Design Technology™ to unlock industrial-scale cell-free biomanufacturing across multiple sectors.

"Cell-free manufacturing has long promised faster, cleaner production, but until now it has been constrained by the capabilities of natural enzymes," said Alexandre Zanghellini, Ph.D., cofounder and CEO of Arzeda. "By combining our generative AI enzyme design platform with these new NSF resources, we will remove those constraints. This will unlock scalable, cost-effective enzyme cascades that were previously impossible and open markets an order of magnitude larger than today."

Transforming Cell-Free Manufacturing

• Unlocking New Chemistry: Arzeda will design high-performance enzymes that work with cost-effective, highly stable non-natural cofactors. This enables reactions that were previously uneconomic in cell-free systems.
• Scaling Sustainable Production: By addressing key cost and stability barriers, the project will expand the range of products that can be made cell-free, from bio-based materials to specialty chemicals.
• Proven Track Record: Arzeda's ViaLeaf™ Reb M natural sweetener already demonstrates cell-free biomanufacturing at commercial scale (500 MT/yr), providing a strong foundation for the new work.

Collaborative Ecosystem

Under the award, Arzeda will lead a consortium of leading academic institutions, including Stanford, the University of North Carolina at Chapel Hill, University of California, Irvine, and University of California, Davis. The multidisciplinary team will integrate AI-driven protein design, high-throughput testing, and advanced bioprocess engineering to propel cell-free technology toward widespread industrial adoption.

NSF Acknowledgment

Research reported in this release is supported by the U.S. National Science Foundation: NSF USPRD award #2449206. Any opinions, findings, and conclusions or recommendations expressed are those of the authors and do not necessarily reflect the views of the NSF. NSF award announcement: https://www.nsf.gov/news/nsf-invests-nearly-32m-accelerate-novel-ai-driven-approaches

About Arzeda

Arzeda develops innovative products powered by its Intelligent Protein Design Technology™, using generative AI-driven design to create, validate, and manufacture new proteins and enzymes that enhance our lives and protect our planet. We commercialize with Fortune 500 go-to-market partners across multiple industries, enabling higher-performing, more cost-effective solutions that are healthier and sustainable. For more information, please visit www.arzeda.com.

Media Contact
[email protected]

SOURCE Arzeda